U.K. private equity firm buys out SteriPack
2022-07-07
并购
SteriPack announced that United Kingdom-based private equity firm Inflexion Private Equity Partners led a buyout of the company.
According to a news release, the strategic partnership poises SteriPack — which provides holistic and integrated product life-cycle management services — for accelerated growth, geographical expansion and an enhanced service offering to better support current and future customers.
Funding from the buyout will support the business’ efforts to scale globally as it benefits from market growth and further international expansion opportunities. The company added that it is well placed to undertake further acquisitions with the support of Inflexion.
Florencia Kassai, partner and head of Inflexion’s buyout fund, said in the release that SteriPack is an “extremely successful niche market player” and the company is excited to bring its experience to help management accelerate growth.
“We’re very proud of our strong growth record and are keen to build on it to take SteriPack even further as we become even more valued partners to our customers through expansion of our capabilities and geographic footprint,” SteriPack CEO Andrew McLean said. “Inflexion’s presence in our core markets of Europe, Asia and the US as well as its extensive M&A experience make it the ideal partner to support our future international growth.”
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。